# NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction

> **NCT03264859** · — · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- No-Reflow Phenomenon
- STEMI - ST Elevation Myocardial Infarction

## Interventions

- **DIAGNOSTIC_TEST:** NGAL levels early and post STEMI

## Key facts

- **NCT ID:** NCT03264859
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-15
- **Primary completion:** 2018-10-31
- **Final completion:** 2018-10-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-08-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03264859

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03264859, "NGAL and Its Association With the No-reflow Phenomenon in ST-elevation Myocardial Infarction". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03264859. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*